Comparing Epclusa vs Mavyret
| Epclusa | Mavyret |
|
|---|
| Epclusa (sofosbuvir / velpatasvir) | Mavyret (glecaprevir / pibrentasvir) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Epclusa is a combination tablet containing velpatasvir and sofosbuvir. It may be used to treat all six genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Prescription only
Mavyret is an antiviral combination agent that is approved to treat all six genotypes (1-6) of hepatitis C virus (HCV) in adults and children aged 12 years of age and older. It is one of the most... View more |
Related suggestions |
|||||||||||||||
| More about Epclusa (sofosbuvir / velpatasvir) | More about Mavyret (glecaprevir / pibrentasvir) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Epclusa has an average rating of 7.7 out of 10 from a total of 392 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 12% reported a negative effect. |
Mavyret has an average rating of 8.4 out of 10 from a total of 420 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Epclusa side effects in more detail. |
See also: Mavyret side effects in more detail. |
||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Epclusa prices |
View all Mavyret prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
27 hours |
13 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 188 drugs are known to interact with Epclusa:
|
A total of 190 drugs are known to interact with Mavyret:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
June 28, 2016 |
August 03, 2017 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.